Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study.
Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study.
复制标题
DOI：
10.2196/24639
复制
发表时间：
2021-04-09
影响因子：
7.4
通讯作者：
Bajaj JS
中科院分区：
文献类型：
--
作者：
Acharya C;Sehrawat TS;McGuire DB;Shaw J;Fagan A;McGeorge S;Olofson A;White MB;Gavis E;Kamath PS;Bergstrom L;Bajaj JS
Health information technology (IT) interventions to decrease readmissions for cirrhosis may be limited by patient-associated factors. The aim of this study was to determine perspectives regarding adoption versus refusal of health IT interventions among patient-caregiver dyads. Inpatients with cirrhosis and their caregivers were approached to participate in a randomized health IT intervention trial requiring daily contact with research teams via the Patient Buddy app. This app focuses on ascites, medications, and hepatic encephalopathy over 30 days. Regression analyses for characteristics associated with acceptance were performed. For those who declined, a semistructured interview was performed with themes focused on caregivers, protocol, transport/logistics, technology demands, and privacy. A total of 349 patient-caregiver dyads were approached (191 from Virginia Commonwealth University, 56 from Richmond Veterans Affairs Medical Center, and 102 from Mayo Clinic), 87 of which (25%) agreed to participate. On regression, dyads agreeing included a male patient (odds ratio [OR] 2.08, P=.01), gastrointestinal bleeding (OR 2.3, P=.006), or hepatic encephalopathy admission (OR 2.0, P=.01), whereas opioid use (OR 0.46, P=.03) and alcohol-related etiology (OR 0.54, P=.02) were associated with refusal. Race, study site, and other admission reasons did not contribute to refusing participation. Among the 262 dyads who declined randomization, caregiver reluctance (43%), perceived burden (31%), technology-related issues (14%), transportation/logistics (10%), and others (4%), but not privacy, were highlighted as major concerns. Patients with cirrhosis admitted with hepatic encephalopathy and gastrointestinal bleeding without opioid use or alcohol-related etiologies were more likely to participate in a health IT intervention focused on preventing readmissions. Caregiver and study burden but not privacy were major reasons to decline participation. Reducing perceived patient-caregiver burden and improving communication may improve participation. ClinicalTrials.gov NCT03564626; https://www.clinicaltrials.gov/ct2/show/NCT03564626
登录
查看更多内容
DOI：
10.1016/j.cgh.2015.08.041
发表时间：
2016-05
期刊：
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子：
--
作者：
Tapper EB;Finkelstein D;Mittleman MA;Piatkowski G;Chang M;Lai M
通讯作者：
Lai M
影响因子：
6.7
作者：
Ganapathy, Dinesh;Acharya, Chathur;Bajaj, Jasmohan S.
通讯作者：
Bajaj, Jasmohan S.
DOI：
10.1002/hep.28414
发表时间：
2016-07
期刊：
Hepatology (Baltimore, Md.)
影响因子：
--
作者：
Bajaj JS;Reddy KR;Tandon P;Wong F;Kamath PS;Garcia-Tsao G;Maliakkal B;Biggins SW;Thuluvath PJ;Fallon MB;Subramanian RM;Vargas H;Thacker LR;O'Leary JG;North American Consortium for the Study of End-Stage Liver Disease
通讯作者：
North American Consortium for the Study of End-Stage Liver Disease
影响因子：
3.6
作者：
Fabrellas, Nuria;Moreira, Rebeca;Gines, Pere
通讯作者：
Gines, Pere
影响因子：
9.8
作者：
Kanwal, Fasiha;Tansel, Aylin;El-Serag, Hashem B.
通讯作者：
El-Serag, Hashem B.